HSBC Holdings
ATOS icon

HSBC Holdings’s Atossa Therapeutics ATOS Stock Holding History

HSBC Holdings’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,196
Closed -$68.6K – 2715
2025
Q2 		$68.6K Buy
5,196
+4,211
+428% +$50.3K ﹤0.01% 2903
2025
Q1 		$9.98K Sell
985
-7
-0.7% -$85 ﹤0.01% 2984
2024
Q4 		$14.1K Sell
992
-89
-8% -$1.74K ﹤0.01% 3062
2024
Q3 		$25.1K Buy
+1,081
New +$21.8K ﹤0.01% 2933

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

HSBC Holdings's ATOS Position: Q3 2025 in Review

HSBC Holdings sold out of Atossa Therapeutics (ATOS) in Q3 2025, closing a stake of 5,196 shares — an estimated $68.6K sold.

HSBC Holdings first reported a position in ATOS in Q3 2024 and held it in 4 quarters. The position peaked at $68.6K in Q2 2025. 66 funds tracked by Wall St. Rank hold ATOS as of Q3 2025.

  • HSBC Holdings reported no remaining Atossa Therapeutics position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 5,196 Atossa Therapeutics shares in Q3 2025, an estimated $68.6K.
  • HSBC Holdings first reported a position in Atossa Therapeutics in Q3 2024 and held it in 4 quarters.
  • HSBC Holdings's Atossa Therapeutics position peaked at $68.6K in Q2 2025.
  • 66 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.